Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

9201

1

Livento Group, Inc. Livento Group Reports Decline in Revenue and Net Loss for Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9202

1

Iterum Therapeutics plc Iterum Therapeutics Reports Financial Developments, Raises Capital, and Faces Challenges

Via official filing (AI summary) | 6 months ago | 0 comments

9203

1

FITLIFE BRANDS, INC. FitLife Brands Reports 15% Revenue Growth, 81% Net Income Increase in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9204

1

ABEONA THERAPEUTICS INC. Abeona Therapeutics Reports Significant Financial Growth and Advancements in Lead Gene Therapy Program

Via official filing (AI summary) | 6 months ago | 0 comments

9205

1

Akoustis Technologies, Inc. Akoustis Technologies Reports 28.6% Revenue Growth, Reduced Losses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9206

1

Invivyd, Inc. Invivyd Reports $9.3M in Product Revenue, Substantial Losses in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9207

1

Canoo Inc. Canoo Reports 72% Revenue Growth, Net Income Turnaround in Q3 2024, Despite Operational Losses and Cash Decline

Via official filing (AI summary) | 6 months ago | 0 comments

9208

1

Longduoduo Co Ltd Longduoduo Reports 52% Revenue Decline, Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9209

1

Agape ATP Corp Agape ATP Corporation Reports Decline in Revenue and Profitability in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9210

1

Argo Group International Holdings, Inc. Argo Group Reports Mixed Financial Results Following Merger with Brookfield Wealth Solutions

Via official filing (AI summary) | 6 months ago | 0 comments

9211

1

Cabaletta Bio, Inc. Cabaletta Bio Reports Increased R&D Expenses and Net Losses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9212

1

bluebird bio, Inc. bluebird bio Reports Significant Financial Decline, Net Loss Widens in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9213

1

Shattuck Labs, Inc. Shattuck Labs Reports Revenue Growth, Improved Losses, and Restructuring Efforts in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

9214

1

BK Technologies Corp BK Technologies Reports Improved Revenue, Profitability, and Strategic Progress in Q3 and Nine Months of 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9215

1

Longevity Health Holdings, Inc. Carmell Corporation Reports Significant Financial Decline, Net Loss in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

9216

1

Contango ORE, Inc. Contango ORE, Inc. Reports Significant Financial Developments, Net Loss Despite Operational Progress and Strategic Growth

Via official filing (AI summary) | 6 months ago | 0 comments

9217

1

Protalix BioTherapeutics, Inc. Protalix BioTherapeutics Reports 36% Revenue Decline, Improved Operating Loss in Nine Months Ending September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9218

1

MOVING iMAGE TECHNOLOGIES INC. Moving iMage Technologies Reports 20.8% Revenue Decline, Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9219

1

Sino Green Land Corp. Sino Green Land Corporation Reports 16% Revenue Decline, Narrows Operating Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9220

1

LadRx Corp LadRx Corporation Reports Significant Financial Decline, Net Loss, and FDA Approval of Arimoclomol

Via official filing (AI summary) | 6 months ago | 0 comments

9221

1

Antiaging Quantum Living Inc. Antiaging Quantum Living Inc. Reports Significant Revenue Growth, Net Loss, and Cash Flow Concerns in 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

9222

1

HARROW, INC. Harrow, Inc. Reports 44% Revenue Growth, Net Loss Widens in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9223

1

Bubblr Inc. Bubblr, Inc. Reports Mixed Results for Q3 2024, with Revenue Growth and Reduced Losses

Via official filing (AI summary) | 6 months ago | 0 comments

9224

1

AEye, Inc. AEye Reports 45% Decline in Q3 Revenue, Improves Operational Losses Amid Shift to Automotive Focus

Via official filing (AI summary) | 6 months ago | 0 comments

9225

1

Theravance Biopharma, Inc. Theravance Biopharma Reports 7% Revenue Growth, Net Loss Widens in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments